| pubmed-article:11383755 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11383755 | lifeskim:mentions | umls-concept:C0025289 | lld:lifeskim |
| pubmed-article:11383755 | lifeskim:mentions | umls-concept:C0121772 | lld:lifeskim |
| pubmed-article:11383755 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:11383755 | lifeskim:mentions | umls-concept:C0010174 | lld:lifeskim |
| pubmed-article:11383755 | lifeskim:mentions | umls-concept:C0031529 | lld:lifeskim |
| pubmed-article:11383755 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11383755 | pubmed:dateCreated | 2001-5-31 | lld:pubmed |
| pubmed-article:11383755 | pubmed:abstractText | Haemophilus influenzae type b (Hib) meningitis is associated with high mortality and serious sequelae in children under 5 years of age. Vaccines which can prevent this infection are available. | lld:pubmed |
| pubmed-article:11383755 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11383755 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11383755 | pubmed:citationSubset | T | lld:pubmed |
| pubmed-article:11383755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11383755 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11383755 | pubmed:issn | 1170-7690 | lld:pubmed |
| pubmed-article:11383755 | pubmed:author | pubmed-author:SaloleE GEG | lld:pubmed |
| pubmed-article:11383755 | pubmed:author | pubmed-author:TaylorS JSJ | lld:pubmed |
| pubmed-article:11383755 | pubmed:author | pubmed-author:ArmourC LCL | lld:pubmed |
| pubmed-article:11383755 | pubmed:author | pubmed-author:LimcangcoM... | lld:pubmed |
| pubmed-article:11383755 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11383755 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11383755 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11383755 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11383755 | pubmed:pagination | 391-400 | lld:pubmed |
| pubmed-article:11383755 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:meshHeading | pubmed-meshheading:11383755... | lld:pubmed |
| pubmed-article:11383755 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11383755 | pubmed:articleTitle | Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines. | lld:pubmed |
| pubmed-article:11383755 | pubmed:affiliation | Department of Pharmacy, College of Pharmacy, University of the Philippines, Manila. | lld:pubmed |
| pubmed-article:11383755 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11383755 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11383755 | lld:pubmed |
